Fox P D, Vessey S J, Forshaw M L, Serjeant G R
Medical Research Council Laboratories, University of the West Indies, Kingston, Jamaica.
Br J Ophthalmol. 1991 Apr;75(4):229-31. doi: 10.1136/bjo.75.4.229.
The natural history of untreated proliferative sickle retinopathy (PSR) has been observed in 35 patients (40 eyes) with homozygous sickle cell (SS) disease and in 112 patients (114 eyes) with sickle cell-haemoglobin C (SC) disease over a mean follow-up period of 4.5 years (range 0.5-14.0 years). In both genotypes progression of PSR was most frequent between ages 20 and 39 years. Spontaneous regression was more common in SS disease (p = 0.01), and more likely to proceed to complete non-perfusion. In SC disease PSR tended to be stable in patients aged 40 and over, and non-perfused PSR lesions were significantly more likely to reperfuse (p = 0.01) than in SS disease. In both genotypes regression was not influenced by size or elevation of the PSR lesion. The tendency for PSR to regress in SS disease suggests that treatment is unnecessary in SS patients aged 40 and over.
在平均随访期4.5年(范围0.5 - 14.0年)内,对35例纯合子镰状细胞(SS)病患者(40只眼)和112例镰状细胞 - 血红蛋白C(SC)病患者(114只眼)观察了未经治疗的增殖性镰状视网膜病变(PSR)的自然病程。在两种基因型中,PSR进展最常发生在20至39岁之间。自发消退在SS病中更常见(p = 0.01),并且更有可能发展为完全无灌注。在SC病中,40岁及以上患者的PSR往往稳定,与SS病相比,无灌注的PSR病变再灌注的可能性显著更高(p = 0.01)。在两种基因型中,消退均不受PSR病变大小或隆起的影响。SS病中PSR有消退趋势表明,40岁及以上的SS患者无需治疗。